ミネソタ州オルムステッド郡の心不全と保存されたエジェクション分子を患っている人の心臓構造と心室血管機能
Carolyn S P Lam1, Véronique L Roger, Richard J Rodeheffer
1Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905, USA.
Circulation
|April 4, 2007
まとめ
正常噴出分数 (HFnlEF) の心不全は,下痢機能の障害と硬さの増加に関連しています. 立方体機能不全の進行は高血圧性心疾患の鍵であり,HFnlEFの発達に影響を及ぼします.
科学分野:
- 心臓病学 心臓病学
- 生理学 生理学とは
背景:
- 正常噴出分数 (HFnlEF) の心不全の病理生理学には,下静脈機能不全,硬化,および体積膨張が含まれます.
- HFnlEFにおける心臓メカニズムの非侵襲的な特徴化は,疾患の進行を理解するために重要である.
研究 の 目的:
- HFnlEF患者および対照群において,左心室の体積,動脈の弾性,心室の弾性およびリラックスを非侵襲的に特徴付ける.
- HFnlEFの発生におけるダイアストリック機能障害の役割を調査する.
主な方法:
- 心血管疾患のない患者,高血圧患者,HFnlEF患者による将来的な登録.
- エコドープラーを用いて,末期ダイアストリック容量,血圧,脳卒中容量,射出分子を測定し,弾性パラメータを決定した.
- 組織ドップラーとダイアストリック曲線フィッティング (アルファとベータ定数) を用いて,リラックスと硬さを評価した.
主要な成果:
- HFnlEFの患者は,対照群と比較して,末期ダイアストリック体積指数と心臓の出力量が低く,末期ダイアストリック圧力が上昇しました.
- 動脈と心室の終末シストリック弾力性は,高血圧対照群およびHFnlEF患者と健康な対照群で上昇した.
- HFnlEFの患者は,両方の対照群よりも,リラックスが低下し,静脈の硬さが増加することが示されました.
結論:
- 静脈動脈機能不全の進行は,HFnlEFの発症の重要な要因であり,特に高血圧性心疾患において重要である.
- 非侵襲的評価は,HFnlEFの明確な機械的異常を明らかにし,下痢機能不全を強調しています.
さらに関連する動画
関連する概念動画
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


